These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 7536279

  • 1. [The effects of COP-BLAM regimen with G-CSF for intermediate and high grade non-Hodgkin's lymphoma].
    Niitsu N, Umeda M.
    Rinsho Ketsueki; 1995 Feb; 36(2):84-90. PubMed ID: 7536279
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment with ACVP-16 for relapsed and refractory non-Hodgkin's lymphoma].
    Niitsu N, Hara A, Umeda M, Shirai T.
    Rinsho Ketsueki; 1993 Jul; 34(7):829-34. PubMed ID: 7689661
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The COP-BLAM III therapy of non-Hodgkin's lymphoma].
    Arai N, Hara A, Umeda M, Shirai T.
    Rinsho Ketsueki; 1991 Nov; 32(11):1447-52. PubMed ID: 1721937
    [Abstract] [Full Text] [Related]

  • 7. CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
    Doorduijn JK, van der Holt B, van Imhoff GW, van der Hem KG, Kramer MH, van Oers MH, Ossenkoppele GJ, Schaafsma MR, Verdonck LF, Verhoef GE, Steijaert MM, Buijt I, Uyl-de Groot CA, van Agthoven M, Mulder AH, Sonneveld P.
    J Clin Oncol; 2003 Aug 15; 21(16):3041-50. PubMed ID: 12915593
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
    Gobbi PG, Ghirardelli ML, Avanzini P, Baldini L, Quarta G, Stelitano C, Broglia C, Loni C, Silingardi V, Ascari E.
    Haematologica; 2000 Mar 15; 85(3):263-8. PubMed ID: 10702814
    [Abstract] [Full Text] [Related]

  • 10. [COP-BLAM III regimen for elderly non-Hodgkin's lymphoma].
    Niitsu N, Umeda M, Shirai T.
    Nihon Ronen Igakkai Zasshi; 1993 Sep 15; 30(9):753-8. PubMed ID: 7693992
    [Abstract] [Full Text] [Related]

  • 11. Biweekly COP-BLAM (cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin and procarbazine) regimen combined with granulocyte colony stimulating factor (G-CSF) for intermediate-grade non-Hodgkin's lymphoma.
    Niitsu N, Umeda M.
    Eur J Haematol; 1996 Mar 15; 56(3):163-7. PubMed ID: 8598236
    [Abstract] [Full Text] [Related]

  • 12. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
    Nishioka T, Tsuchiya K, Nishioka S, Kitahara T, Ohmori K, Homma A, Aoyma H, Shindoh M, Shirato H.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):847-52. PubMed ID: 15465202
    [Abstract] [Full Text] [Related]

  • 13. [A comparative study of CHOP therapy and COP-BLAM therapy for non-Hodgkin's lymphoma in elderly patients].
    Arai N, Hara A, Kaneko H, Umeda M, Shirai T.
    Nihon Ronen Igakkai Zasshi; 1991 Sep 01; 28(5):672-7. PubMed ID: 1721658
    [Abstract] [Full Text] [Related]

  • 14. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
    Santini G, Coser P, Congiu AM, Salvagno L, De Souza C, Sertoli MR, Olivieri A, Chisesi T, Rubagotti A, Truini M, Contu A, Porcellini A, Zambaldi G, Nati S, Marino G, Rizzoli V.
    Haematologica; 2000 Feb 01; 85(2):160-6. PubMed ID: 10681723
    [Abstract] [Full Text] [Related]

  • 15. [Prognostic factors of follicular lymphoma treated with combination chemotherapy].
    Niitsu N, Umeda M.
    Rinsho Ketsueki; 1997 Jun 01; 38(6):496-504. PubMed ID: 9248325
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B, Jancić-Nedeljkov R, Sretenović M, Milivojević G, Janković S, Petrović M.
    Srp Arh Celok Lek; 1998 Jun 01; 126(9-10):345-8. PubMed ID: 9863405
    [Abstract] [Full Text] [Related]

  • 17. Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma.
    Smalley RV, Andersen JW, Hawkins MJ, Bhide V, O'Connell MJ, Oken MM, Borden EC.
    N Engl J Med; 1992 Nov 05; 327(19):1336-41. PubMed ID: 1406835
    [Abstract] [Full Text] [Related]

  • 18. Effects of recombinant granulocyte colony-stimulating factor (G-CSF) in patients treated with ProMACE-CytaBOM for HIV-related non-Hodgkin's lymphoma (NHL).
    Rossi G, Donisi A, Casari S, Re A, Stellini R, Cadeo G, Carosi G.
    Haematologica; 1998 Apr 05; 83(4):317-22. PubMed ID: 9592981
    [Abstract] [Full Text] [Related]

  • 19. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
    Yuan ZY, Li YX, Zhao LJ, Gao YH, Liu XF, Gu DZ, Qian TN, Yu ZH.
    Zhonghua Zhong Liu Za Zhi; 2004 Jul 05; 26(7):425-9. PubMed ID: 15355649
    [Abstract] [Full Text] [Related]

  • 20. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
    Sun XF, Su YS, Liu DG, Jiang WQ, He YJ, Lin TY, Huang HQ, Zhang L, Xia ZJ, Li YH, Zhou ZM, Chen XQ, Xia Y, Zhen ZJ, Guan ZZ.
    Ai Zheng; 2004 Aug 05; 23(8):933-8. PubMed ID: 15301718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.